Entera Bio Ltd. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2021 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Entera Bio Ltd. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2023.
- Entera Bio Ltd. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
- Entera Bio Ltd. annual Deferred Income Tax Expense (Benefit) for 2024 was $14K, a 51.7% decline from 2023.
- Entera Bio Ltd. annual Deferred Income Tax Expense (Benefit) for 2023 was $29K, a 83.3% decline from 2022.
- Entera Bio Ltd. annual Deferred Income Tax Expense (Benefit) for 2022 was $174K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)